Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Innovative Pharmaceutical Biotech ( (HK:0399) ) just unveiled an announcement.
Innovative Pharmaceutical Biotech Limited has announced the appointment of three new directors, effective April 11, 2025. Mr. Zhang Shen will join as an executive director, bringing his expertise in blockchain technology and asset management, while Mr. Zhang Yi will serve as a non-executive director, leveraging his experience in software development and blockchain technologies. Additionally, Ms. Sun Sizheng has been appointed as an independent non-executive director. These appointments are expected to strengthen the company’s leadership team and enhance its strategic direction in the biotechnology sector.
More about Innovative Pharmaceutical Biotech
Innovative Pharmaceutical Biotech Limited operates in the pharmaceutical and biotechnology industry, focusing on the development and commercialization of innovative healthcare solutions. The company is involved in various aspects of drug development and aims to address unmet medical needs in the market.
YTD Price Performance: -20.48%
Average Trading Volume: 848,352
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$304.3M
For a thorough assessment of 0399 stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue